In 2004 was created Caixa Capital Risc, which is appeared as VC. The fund was located in Europe if to be more exact in Spain. The main department of described VC is located in the Barcelona.
The fund has no exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Health Care, SaaS. Among the most popular portfolio startups of the fund, we may highlight CornerJob, Minoryx Therapeutics, Groupalia. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Spain. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The overall number of key employees were 3.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Caixa Capital Risc, startups are often financed by Wayra, Ysios Capital, Cabiedes & Partners. The meaningful sponsors for the fund in investment in the same round are Bonsai Venture Capital SCR, Cabiedes & Partners, Xesgalicia. In the next rounds fund is usually obtained by Ysios Capital, Idinvest Partners, Sweet Capital.
Comparing to the other companies, this Caixa Capital Risc performs on 19 percentage points less the average number of lead investments. The usual things for fund are deals in the range of 1 - 5 millions dollars. The increased amount of exits for fund were in 2018. The average startup value when the investment from Caixa Capital Risc is 10-50 millions dollars. The fund is constantly included in 7-12 deals per year. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
KIT-AR | $3M | 27 Feb 2024 | London, England, United Kingdom | ||
Nanusens | 25 Sep 2023 | South Hams, England, United Kingdom | |||
Appentra | $5M | 19 Sep 2023 | A Coruña, Galicia, Spain | ||
INARI | $5M | 07 Sep 2023 | Barcelona, Catalonia, Spain | ||
Build38 | $15M | 07 Feb 2023 | Munich, Bavaria, Germany | ||
mlean | $3M | 30 Jan 2023 | Valladolid, Castilla y Leon, Spain | ||
Recognai | $1M | 25 Jan 2023 | Madrid, Community of Madrid, Spain | ||
Mobile Media Content - TICKETING3D | $2M | 06 Dec 2022 | Miami, Florida, United States | ||
3D Digital Venue | $2M | 05 Dec 2022 | Barcelona, Catalonia, Spain |
– MedLumics, a privately held medical device company developing AblaView®, the first optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation (AF), announced today that it has closed an upsized EUR 18 million (USD 21.7 million) financing round.
– MedLumics’ optical catheter displays lesion creation in real-time providing the physician with direct visual confirmation of conduction tissue denaturation.
– This round was led by Asabys Partners, along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors Andera Partners, Caixa Capital Risc and Innogest Capital II.
– MedLumics is now ready to initiate first in-human regulatory clinical studies and automate scalable product manufacturing.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
KIT-AR | $3M | 27 Feb 2024 | London, England, United Kingdom | ||
Nanusens | 25 Sep 2023 | South Hams, England, United Kingdom | |||
Appentra | $5M | 19 Sep 2023 | A Coruña, Galicia, Spain | ||
INARI | $5M | 07 Sep 2023 | Barcelona, Catalonia, Spain | ||
Build38 | $15M | 07 Feb 2023 | Munich, Bavaria, Germany | ||
mlean | $3M | 30 Jan 2023 | Valladolid, Castilla y Leon, Spain | ||
Recognai | $1M | 25 Jan 2023 | Madrid, Community of Madrid, Spain | ||
Mobile Media Content - TICKETING3D | $2M | 06 Dec 2022 | Miami, Florida, United States | ||
3D Digital Venue | $2M | 05 Dec 2022 | Barcelona, Catalonia, Spain |